Clinical trials
Phase 1/2 Urogenital Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Advanced Accelerator Applications | 1 |
| Blue Earth Therapeutics Ltd | 1 |
| Janssen Research & Development, LLC | 1 |
| Lipac Oncology LLC | 1 |
| M.D. Anderson Cancer Center | 1 |
| Marengo Therapeutics, Inc. | 1 |
| NanOlogy, LLC | 1 |
| National Cancer Institute (NCI) | 1 |
| Novartis Pharmaceuticals | 1 |
| Steba Biotech S.A. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urogenital Neoplasms | 10 |
| Prostatic Neoplasms | 5 |
| Genital Neoplasms, Male | 4 |
| Melanoma | 3 |
| Neoplasms | 3 |
| Neoplasms by Site | 3 |
| Prostatic Diseases | 3 |
| Urinary Bladder Neoplasms | 3 |
| Carcinoma | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.